| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
* Section of Medical Inflammation Research, Lund University, Lund, Sweden; and
Experimental Immunology, Department of Research, University Hospital, Basel, Switzerland
T cell recognition of the type II collagen (CII) 260–270 peptide is a bottleneck for the development of collagen-induced arthritis (CIA), an animal model of rheumatoid arthritis. We have earlier made C3H.Q mice expressing CII with glutamic acid instead of aspartic acid at position 266 (the MMC-C3H.Q mouse), similar to the rat and human CII epitope, which increases binding to MHC class II and leads to effective presentation of the peptide in vivo. These mice show T cell tolerance to CII, but also develop severe arthritis. The present investigation shows that non-MHC genes play a decisive role in determining tolerance and arthritis susceptibility. We bred MMC into B10.Q mice, which display similar susceptibility to CIA induced with rat CII as the C3H.Q mice. In contrast to MMC-C3H.Q mice, MMC-B10.Q mice were completely resistant to arthritis. Nontransgenic (B10.Q x C3H.Q)F1 mice were more susceptible to CIA than either of the parental strains, but introduction of the MMC transgene leads to CIA resistance, showing that the protection is dominantly inherited from B10.Q. In an attempt to break the B10-mediated CIA protection in MMC-transgenic mice, we introduced a transgenic, CII-specific, TCR 
-chain specific for the CII260–270 glycopeptide, in the highly CIA-susceptible (B10.Q x DBA/1)F1 mice. The magnification of the autoreactive CII-specific T cell repertoire led to increased CIA susceptibility, but the disease was less severe than in mice lacking the MMC transgene. This finding is important for understanding CIA and perhaps also rheumatoid arthritis, as in both diseases MHC class II-restricted T cell recognition of the glycosylated CII peptide occurs.
This article has been cited by other articles:
|
|
 |
|
  K. Hagenow, K. A. Gelderman, M. Hultqvist, P. Merky, J. Backlund, O. Frey, T. Kamradt, and R. Holmdahl Ncf1-Associated Reduced Oxidative Burst Promotes IL-33R+ T Cell-Mediated Adjuvant-Free Arthritis in Mice J. Immunol., July 15, 2009; 183(2): 874 - 881. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A M Blom, K S Nandakumar, and R Holmdahl C4b-binding protein (C4BP) inhibits development of experimental arthritis in mice Ann Rheum Dis, January 1, 2009; 68(1): 136 - 142. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Hultqvist, J. Backlund, K. Bauer, K. A. Gelderman, and R. Holmdahl Lack of Reactive Oxygen Species Breaks T Cell Tolerance to Collagen Type II and Allows Development of Arthritis in Mice J. Immunol., August 1, 2007; 179(3): 1431 - 1437. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. P. Treschow, J. Backlund, R. Holmdahl, and S. Issazadeh-Navikas Intrinsic Tolerance in Autologous Collagen-Induced Arthritis Is Generated by CD152-Dependent CD4+ Suppressor Cells J. Immunol., June 1, 2005; 174(11): 6742 - 6750. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Yamada, B. Dzhambazov, R. Bockermann, T. Blom, and R. Holmdahl A Transient Post-Translationally Modified Form of Cartilage Type II Collagen Is Ignored by Self-Reactive T Cells J. Immunol., October 1, 2004; 173(7): 4729 - 4735. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
